Levothroid and Tekturna drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Levothroid (levothyroxine sodium) and Tekturna (aliskiren hemifumarate). Common drug interactions include blood creatinine increased among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Levothroid and Tekturna. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Levothroid?

Levothroid has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. eHealthMe is studying from 8,974 Levothroid users. Check the latest studies of Levothroid.

What is Tekturna?

Tekturna has active ingredients of aliskiren hemifumarate. It is often used in high blood pressure. eHealthMe is studying from 4,730 Tekturna users. Check the latest studies of Tekturna.

On Jul, 14, 2026

13 people who take Levothroid and Tekturna together, and have interactions are studied.

Levothroid and Tekturna drug interactions.

What are the common drug interactions of Levothroid and Tekturna, by gender? *:

female:

Blood creatinine increased
Dizziness
Lip blister
Lip exfoliation
Lip swelling
Pruritus (severe itching of the skin)
Rash
Secretion discharge
Upper respiratory tract infection
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)

male:

Chronic kidney disease
Renal failure (kidney dysfunction)
International normalised ratio increased
Lung neoplasm (tumour of lung)
Nephrogenic anaemia (anaemia due to kidney disease)
Proteinuria (presence of protein in the urine)
Renal injury (kidney injury)
Sepsis (a severe blood infection that can lead to organ failure and death)
Type 2 diabetes mellitus
Acute respiratory failure

What are the common drug interactions of Levothroid and Tekturna, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Chronic kidney disease
Renal failure (kidney dysfunction)
Cardiac failure congestive
Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
Hypercalcaemia (elevated calcium (ca+) level in the blood)
Sepsis (a severe blood infection that can lead to organ failure and death)
Type 2 diabetes mellitus

40-49:

n/a

50-59:

Acute respiratory failure
Cardiac arrest
Cardiomyopathy (weakening of the heart muscle)
Chronic kidney disease
Nephrogenic anaemia (anaemia due to kidney disease)
Renal failure (kidney dysfunction)
Renal injury (kidney injury)

60+:

Dyspnoea (difficult or laboured respiration)
Lip blister
Blood creatine increased
Blood creatinine increased
Blood glucose increased
Blood magnesium decreased
Blood potassium increased
Blood sodium decreased
Blood urea increased
Bradycardia (abnormally slow heart action)

What are the existing conditions these people have? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 38.46%
Gastric Ulcer (stomach ulcer): 4 people, 30.77%
Gastric Disorder (disease of stomach): 4 people, 30.77%
Iron Deficiency: 3 people, 23.08%
Anaemia (lack of blood): 3 people, 23.08%
Renal Cell Carcinoma (a kidney cancer): 1 person, 7.69%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 7.69%
Pain: 1 person, 7.69%
Oedema (fluid collection in tissue): 1 person, 7.69%
Multiple Myeloma (cancer of the plasma cells): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Levothroid and Tekturna?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously